Alzheimer’s Clinical Data: High exposure at three significant Alzheimer ... clearance in 2020 as a portable magnetic resonance brain imaging device for producing images that display the internal ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...

Created by Pentagram partner Harry Pearce, the new visual identity was shaped around the concept of "one brand, one ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

That disease is Alzheimer’s disease. Let’s begin with some definitions. Alzheimer’s disease is a degenerative brain disease caused by complex brain changes following cell damage. Symptoms gradually ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

The study expands on prior work (Piccirella et al, JPAD, 2022), positioning U-p53AZ as a robust tool for both early and advanced AD detection. Its potential for clinical application in diagnostic ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Hyperfine (HYPR) announced the presentation of additional research data and images using the Swoop system to image patients with ...

DelveInsight's Neurological Biomarkers Market Insights report provides the current and forecast market analysis, individual ...